Similarly, a new analysis of seven randomized controlled trials testing the drug tirzepatide, or Zepbound, focusing on results in adults over 65, showed that on the highest dose of the drug, seniors lost about 23.3% of their starting weight on average, while younger adults lost about 22.6%
Where IV therapy earns its place is in absorption problems, intense recovery demands, and confirmed shortfalls
NICE guidance recommends FIB-4 and ELF scores to assess fibrosis risk and determine need for specialist hepatology referral
Stable isotope D9-TMA and D9-TMAO (Cambridge Isotope Laboratories, Inc.) were added to the samples as the internal standard for the TMA and TMAO quantification, respectively
serious effects are uncommon when treatment is supervised and doses are tailored